Professeur Patrick MISMETTI
✨ Profil synthétique
IA · 06/05/2026Le Professeur Patrick MISMETTI est un rhumatologue hospitalier à Saint-Priest-en-Jarez avec une activité de recherche importante, comme en témoignent son h-index de 41 et ses 207 publications. Ses domaines de recherche incluent notamment la thrombose veineuse, la fibrillation auriculaire et l'héparine induite thrombocytopénie. Il a également dirigé plusieurs thèses de doctorat dans des domaines variés tels que la pharmacologie, la médecine et la biologie.
Expertises présumées
- Thrombose veineuse
- Fibrillation auriculaire
- Héparine induite thrombocytopénie
- Gériatrie
- Pharmacovigilance
- Épidémiologie
- Essais cliniques
- Thrombose et coagulation sanguine
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Thèses universitaires
Modélisation pharmacocinétique-pharmacodynamique par approche de population de deux antivitamines K, l'Acénocoumarol et la Warfarine : influence de l'éducation des malades et de l'observance au traitement sur la stabilité pharmacodynamique
2001Pharmacologie🎓 Lyon 1Direction : Jean-Pierre Boissel
Interet de l'hemodilution normovolemique et de la section per-operatoire de l'arcade du soleaire : dans la prevention des thromboses veineuses profondes post-operatoires de la chirurgie du genou ; a propos d'un travail retrospectif portant sur 122 malades du service orthopedie du professeur g. bousquet a saint-etienne
1990Médecine🎓 Saint-EtienneDirection : Hervé Decousus
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Direction de thèses
🎓 6 thèses dirigéesRisque hémoragique sous anticoagulants : Vers une prise en charge personnalisée
2017Doctorant·e : Farès Moustafa
Sciences, Ingénierie, Santé🎓 LyonElaboration d'un score de vieillissement : propositions théoriques
2013Doctorant·e : Marianne Sarazin
Biologie Médecine Santé🎓 Saint-EtienneL'infarctus cérébral artériel du nouveau-né à terme : présentation clinique, facteurs de risques et déterminants évolutifs à partir d'une cohorte prospective multicentrique d'épidémiologie descriptive
2011Doctorant·e : Cyrille Renaud
Recherche clinique Innovation technologique🎓 Saint-EtiennePrise en charge diagnostique et thérapeutique des patients suspects d'embolie pulmonaire : problématique particulière en cas de Broncho-Pneumopathie Chronique Obstructive
2011Doctorant·e : Laurent Bertoletti
Recherche clinique Innovation technologique Santé publique🎓 Saint-EtienneDénutrition en cancérologie : repérage des patients à risque
2010Doctorant·e : Alice Lorans
Epidémiologie recherche clinique et innovation🎓 Saint-EtienneIdentification des facteurs de risque pour prévenir les complications thrombotiques et hémorragiques de la grossesse
2009Doctorant·e : Céline Chauleur
Biologie. Médecine. Santé🎓 Saint-Etienne
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
41
h articles cités ≥ h fois chacun. Un h de 41 = 41 publications avec 41+ citations.
Citations
11 838
Publications
207
i10-index
83
Thématiques principales
- Venous Thromboembolism Diagnosis and Management ×122
- Atrial Fibrillation Management and Outcomes ×75
- Heparin-Induced Thrombocytopenia and Thrombosis ×31
- Blood Coagulation and Thrombosis Mechanisms ×19
- Central Venous Catheters and Hemodialysis ×16
Affiliations FR : Inserm · Institute Cancer De La Loire Lucien Neuwirth · Hôpital Nord
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling Study
2025ArticleThrombosis and Haemostasis
Apixaban or rivaroxaban for extended anticoagulation in patients with venous thromboembolism: A post hoc analysis of the renove clinical trial
2025ArticleBlood
Role of platelet α2-adrenoreceptor in biological low response to Clopidogrel for patients with non cardioembolic ischemic stroke or transient ischemic attack
2025ArticleAmerican Journal of Translational Research
Monitoring of biological response to clopidogrel after treatment for non-cardioembolic ischemic stroke or transient ischemic attack
2025ArticleAmerican Journal of Translational Research
Anticoagulant management in emergency settings: 2024 guidelines from the French Society of Emergency Medicine (SFMU), the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Working Group on Perioperative Haemostasis (GIHP)*
2025ArticleAnaesthesia Critical Care & Pain Medicine
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
2025ArticleNew England Journal of Medicine
Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial
2025ArticleThe Lancet
Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
2024ArticleAnaesthesia Critical Care & Pain Medicine
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Lieu de consultation
HOPITAL NORD - CHU42
Avenue ALBERT RAIMOND, 42277 Saint-Priest-en-Jarez
☎ 0477828002Hospitalier
Tarifs & secteur de conventionnement
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 1Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial
Chest · 2022
📚 133 citations🎯 RCR 14.20Top 1% NIH🩺 Clinique - 2Platelets as Key Factors in Inflammation: Focus on CD40L/CD40
Frontiers in immunology · 2022
Lire l'abstract Crossref ↓
Platelets are anucleate cytoplasmic fragments derived from the fragmentation of medullary megakaryocytes. Activated platelets adhere to the damaged endothelium by means of glycoproteins on their surface, forming the platelet plug. Activated platelets can also secrete the contents of their granules, notably the growth factors contained in the α-granules, which are involved in platelet aggregation and maintain endothelial activation, but also contribute to vascular repair and angiogenesis. Platelets also have a major inflammatory and immune function in antibacterial defence, essentially through their Toll-like Receptors (TLRs) and Sialic acid-binding immunoglobulin-type lectin (SIGLEC). Platelet activation also contributes to the extensive release of anti- or pro-inflammatory mediators such as IL-1β, RANTES (Regulated on Activation, Normal T Expressed and Secreted) or CD154, also known as the CD40-ligand. Platelets are involved in the direct activation of immune cells, polynuclear neutrophils (PNNs) and dendritic cells via the CD40L/CD40 complex. As a general rule, all of the studies presented in this review show that platelets are capable of covering most of the stages of inflammation, primarily through the CD40L/CD40 interaction, thus confirming their own role in this pathophysiological condition.
- 3Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
The New England journal of medicine · 2025
📚 92 citations🎯 RCR 39.81🩺 Clinique🔓 Open Access
Publications scientifiques (50) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal41
▼
Transversal41
▼- Complications in Cancer Associated Thrombosis patients on tinzaparin by cancer site and frailty: a pooled analysis
Blood advances · 2026 · Journal Article
Mahe I, Chapelle C, Girard P, Jara-Palomares L, et al.
- Impact of adherence to elastic compression stockings on efficacy to prevent postthrombotic syndrome: a prespecified analysis of the Compression Elastique Evaluation du Syndrome post Thrombotique study
Research and practice in thrombosis and haemostasis · 2026 · Journal Article
Galanaud JP, Genty-Vermorel C, Terriat B, Stansal A, et al.
- Prevention of venous thromboembolism in critically ill patients: current state and future perspectives
European journal of internal medicine · 2025 · Journal Article
Mismetti V, Mismetti P, Bertoletti L
- The management of cancer-associated thromboembolism: Proposals from the French multidisciplinary INNOVTE CAT Working Group
Archives of cardiovascular diseases · 2025 · Journal Article
Mahé I, Benhamou Y, Benmaziane A, Bertoletti L, et al.
🩺 Clinique - Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling Study
Thrombosis and haemostasis · 2025 · Clinical Trial
Delavenne X, Escal J, Helley D, Bertoletti L, et al.
🩺 Clinique - Anticoagulant management in Emergency settings: 2024 guidelines from the French Society of Emergency Medicine (SFMU), the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Working Group on Perioperative Haemostasis (GIHP), endorsed by the French Neurovascular Society
Anaesthesia, critical care & pain medicine · 2025 · Journal Article
Douillet D, Godon A, Rousseau G, Ruiz S, et al.
📚 3 cit.🩺 Clinique - Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
The New England journal of medicine · 2025 · Clinical Trial, Phase III
Mahé I, Carrier M, Mayeur D, Chidiac J, et al.
📚 92 cit.🎯 RCR 39.81🩺 Clinique - Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
Anaesthesia, critical care & pain medicine · 2024 · Journal Article
Godier A, Lasne D, Pernod G, Blais N, et al.
📚 7 cit.🎯 RCR 2.69🩺 Clinique - Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study
Journal of thrombosis and haemostasis : JTH · 2024 · Journal Article
Gouin-Thibault I, Mansour A, Caribotti C, Pierre-Jean M, et al.
📚 2 cit.🩺 Clinique - [Translation into French and republication of: "Cancer-related arterial thromboembolic events"]
La Revue de medecine interne · 2024 · English Abstract
Pernod G, Cohen A, Mismetti P, Sanchez O, et al.
- Latest advances in the reversal strategies for direct oral anticoagulants
Fundamental & clinical pharmacology · 2024 · Journal Article
Escal J, Lanoiselée J, Poenou G, Zufferey P, et al.
📚 3 cit. - Anticoagulant treatment of cancer-associated thromboembolism
Archives of cardiovascular diseases · 2024 · Journal Article
Mahé I, Mayeur D, Couturaud F, Scotté F, et al.
📚 17 cit.🎯 RCR 3.97🔬→🩺 Translationnel - Management of cancer-associated thromboembolism: Introduction
Archives of cardiovascular diseases · 2024 · Journal Article
Mahé I, Sanchez O, Mismetti P
📚 2 cit. - Management of cancer-associated thromboembolism in vulnerable population
Archives of cardiovascular diseases · 2024 · Meta-Analysis
Laporte S, Benhamou Y, Bertoletti L, Frère C, et al.
📚 13 cit.🎯 RCR 2.89🔬→🩺 Translationnel - Cancer-related arterial thromboembolic events
Archives of cardiovascular diseases · 2024 · Journal Article
Pernod G, Cohen A, Mismetti P, Sanchez O, et al.
📚 15 cit.🎯 RCR 3.23🔬→🩺 Translationnel - French guidelines for the treatment of cancer-associated venous thromboembolism - 2023 update
Respiratory medicine and research · 2023 · Review
Mahé I, Meyer G, Girard P, Bertoletti L, et al.
📚 16 cit.🎯 RCR 2.10🔬→🩺 Translationnel - Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial
Thrombosis research · 2023 · Multicenter Study
Rambaud G, Mai V, Motreff C, Sanchez O, et al.
📚 6 cit. - Plasma lipidomic analysis to investigate putative biomarkers of P-glycoprotein activity in healthy volunteers
Clinical and translational science · 2023 · Journal Article
Decaix T, Magny R, Gouin-Thibaut I, Delavenne X, et al.
📚 3 cit. - Inhibition of Factor XI: A New Era in the Treatment of Venous Thromboembolism in Cancer Patients?
International journal of molecular sciences · 2023 · Journal Article
Poenou G, Heestermans M, Lafaie L, Accassat S, et al.
📚 9 cit.🎯 RCR 1.26 - Primary prevention of cancer-associated venous thrombosis: Rationale and challenges in clinical practice
Current research in translational medicine · 2023 · Journal Article
Elalamy I, Cohen-Solal A, Hanon O, Mirabel M, et al.
📚 6 cit. - Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studies
Journal of thrombosis and haemostasis : JTH · 2022 · Randomized Controlled Trial
Fauché A, Presles E, Sanchez O, Jaïs X, et al.
📚 14 cit.🎯 RCR 1.53🩺 Clinique - Using 99mTc-(V)-DMSA to follow the vascular calcification process in vascular smooth muscle cells based on pit-1 expression
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... · 2022 · Journal Article
Bonnefoy PB, Jacqueroux E, Delavenne X, Roche F, et al.
- Pathological Analysis and Clinical Evolution After Radiological Removal of Retrievable Vena Cava Filters
Vascular and endovascular surgery · 2022 · Journal Article
Annweiler T, Bertoletti L, Grange S, Peoc'h M, et al.
📚 2 cit. - Pulmonary Embolism in the Cancer Associated Thrombosis Landscape
Journal of clinical medicine · 2022 · Journal Article
Poenou G, Dumitru Dumitru T, Lafaie L, Mismetti V, et al.
📚 22 cit.🎯 RCR 2.56 - Management of Cancer-Associated Thrombosis in France: A National Survey among Vascular Disease and Supportive Care Specialists
Cancers · 2022 · Journal Article
Mahé I, Chapelle C, Plaisance L, Bertoletti L, et al.
📚 1 cit. - Cardiac Biomarkers in Patients with Acute Pulmonary Embolism
Medicina (Kaunas, Lithuania) · 2022 · Journal Article
Janisset L, Castan M, Poenou G, Lachand R, et al.
📚 15 cit.🎯 RCR 1.88 - Platelet transmission electron microscopy for the assessment of poor biological response to antiplatelet agent: pilot descriptive and prospective study - ELECTROSTROKE
BMJ open · 2022 · Journal Article
Mallouk N, Garcin A, Li G, Epinat M, et al.
📚 1 cit. - Platelets as Key Factors in Inflammation: Focus on CD40L/CD40
Frontiers in immunology · 2022 · Journal Article
Cognasse F, Duchez AC, Audoux E, Ebermeyer T, et al.
📚 111 cit.🎯 RCR 11.02🔬→🩺 Translationnel - The impact of advanced age on anticoagulant therapy for acute venous thromboembolism
Expert opinion on drug metabolism & toxicology · 2022 · Journal Article
Lafaie L, Célarier T, Monreal M, Mismetti P, et al.
📚 5 cit. - Management of acute venous thromboembolism in patients taking antiplatelet therapy
Thrombosis research · 2021 · Journal Article
Giraud M, Catella J, Cognet L, Helfer H, et al.
📚 6 cit. - Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma
Journal of cancer research and clinical oncology · 2021 · Journal Article
Barrau M, Maoui K, Le Roy B, Roblin X, et al.
📚 11 cit. - Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection
Virology journal · 2021 · Clinical Trial
Hamzeh-Cognasse H, Mansour A, Reizine F, Mismetti P, et al.
📚 24 cit.🎯 RCR 1.42🩺 Clinique - The Non-Haemostatic Response of Platelets to Stress: An Actor of the Inflammatory Environment on Regenerative Medicine?
Frontiers in immunology · 2021 · Journal Article
Cognasse F, Hamzeh-Cognasse H, Mismetti P, Thomas T, et al.
📚 9 cit. - Thromboprophylaxis strategies to improve the prognosis of COVID-19
Vascular pharmacology · 2021 · Journal Article
Bertoletti L, Bikdeli B, Zuily S, Blondon M, et al.
📚 7 cit. - Severe Inflammation, Acute Kidney Injury, and Drug-Drug Interaction: Triple Penalty for Prolonged Elimination of Apixaban in Patients With Coronavirus Disease 2019: A Grand Round
Therapeutic drug monitoring · 2021 · Case Reports
Launay M, Demartin AL, Ragey SP, Mismetti P, et al.
📚 4 cit. - Platelet Innate Immune Receptors and TLRs: A Double-Edged Sword
International journal of molecular sciences · 2021 · Journal Article
Ebermeyer T, Cognasse F, Berthelot P, Mismetti P, et al.
📚 62 cit.🎯 RCR 4.41 - An epidemic of redundant meta-analyses
Journal of thrombosis and haemostasis : JTH · 2021 · Journal Article
Chapelle C, Ollier E, Girard P, Frere C, et al.
📚 20 cit.🎯 RCR 1.53🔬→🩺 Translationnel - In memory of Professor Guy Meyer, 1957-2020
Thrombosis research · 2021 · Journal Article
Emmerich J, Girard P, Sanchez O, Mismetti P
- Effects and Side Effects of Platelet Transfusion
Hamostaseologie · 2021 · Journal Article
Cognasse F, Hally K, Fauteux-Daniel S, Eyraud MA, et al.
📚 17 cit.🎯 RCR 1.43🔬→🩺 Translationnel - Recovery from acute kidney injury in patients with pulmonary embolism: A single-center study
Thrombosis research · 2021 · Letter
Murgier M, Fouillet L, Ollier E, Merah A, et al.
📚 10 cit. - Opinion and practice survey about the use of prognostic models in acute pulmonary embolism
Thrombosis research · 2021 · Journal Article
Elias A, Schmidt J, Bellou A, Le Gal G, et al.
📚 6 cit.
Essai clinique6
▼
Essai clinique6
▼- Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial
The Lancet. Haematology · 2026 · Equivalence Trial
Mahé I, Chapelle C, Girard P, Carrier M, et al.
📚 6 cit.🎯 RCR 6.00🩺 Clinique - Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial
Lancet (London, England) · 2025 · Journal Article
Couturaud F, Schmidt J, Sanchez O, Ballerie A, et al.
📚 62 cit.🎯 RCR 25.87🩺 Clinique - Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical Patients
NEJM evidence · 2023 · Clinical Trial
Mottier D, Girard P, Couturaud F, Lacut K, et al.
📚 14 cit.🎯 RCR 2.21🩺 Clinique - Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial
EClinicalMedicine · 2023 · Journal Article
Zuily S, Lefèvre B, Sanchez O, Empis de Vendin O, et al.
📚 15 cit.🎯 RCR 1.59🔬→🩺 Translationnel - Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial
Chest · 2022 · Journal Article
Planquette B, Bertoletti L, Charles-Nelson A, Laporte S, et al.
📚 133 cit.🎯 RCR 14.20🩺 Clinique - Compared to randomized studies, observational studies may overestimate the effectiveness of DOACs: a metaepidemiological approach
Journal of clinical epidemiology · 2021 · Comparative Study
Safieddine M, Chapelle C, Ollier E, Ferdynus C, et al.
📚 12 cit.🎯 RCR 1.05🔬→🩺 Translationnel
Épidémiologie & registres2
▼
Épidémiologie & registres2
▼- Elderly patients with venous thromboembolism: Insights from the RIETE registry
Presse medicale (Paris, France : 1983) · 2024 · Journal Article
Mismetti P, Bertoletti L, Gouin I, Emmerich J, et al.
📚 2 cit. - Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
American journal of cardiovascular drugs : drugs, devices, and other interventions · 2022 · Published Erratum
Blin P, Dureau-Pournin C, Bénichou J, Cottin Y, et al.
Vraie vie / RWE2
▼
Vraie vie / RWE2
▼- Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
American journal of cardiovascular drugs : drugs, devices, and other interventions · 2022 · Published Erratum
Blin P, Dureau-Pournin C, Bénichou J, Cottin Y, et al.
- Compared to randomized studies, observational studies may overestimate the effectiveness of DOACs: a metaepidemiological approach
Journal of clinical epidemiology · 2021 · Comparative Study
Safieddine M, Chapelle C, Ollier E, Ferdynus C, et al.
📚 12 cit.🎯 RCR 1.05🔬→🩺 Translationnel
Gériatrie1
▼
Gériatrie1
▼- Elderly patients with venous thromboembolism: Insights from the RIETE registry
Presse medicale (Paris, France : 1983) · 2024 · Journal Article
Mismetti P, Bertoletti L, Gouin I, Emmerich J, et al.
📚 2 cit.
Pharmacovigilance1
▼
Pharmacovigilance1
▼- Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
American journal of cardiovascular drugs : drugs, devices, and other interventions · 2022 · Published Erratum
Blin P, Dureau-Pournin C, Bénichou J, Cottin Y, et al.
Revue / méta-analyse1
▼
Revue / méta-analyse1
▼- The Ottawa score for prediction of recurrent venous thromboembolism in cancer patients treated with tinzaparin: an individual patient data meta-analysis
Research and practice in thrombosis and haemostasis · 2026 · Journal Article
Chapelle C, Girard P, Jara-Palomares L, Lee AYY, et al.
Datasets & protocoles partagés
Pathological Analysis and Clinical Evolution After Radiological Removal of Retrievable Vena Cava Filters
Collection2022SAGE JournalsObjectiveRetrievable inferior vena cava filters (IVCF) have been developed because permanent filters have been associated with an increased risk of recurrent deep venous thrombosis. There is no data on the interactions o
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Other2017Elsevier BVBackground Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these complications. Methods This was a multicentre, doub
Pathological Analysis and Clinical Evolution After Radiological Removal of Retrievable Vena Cava Filters
Collection2022SAGE JournalsObjectiveRetrievable inferior vena cava filters (IVCF) have been developed because permanent filters have been associated with an increased risk of recurrent deep venous thrombosis. There is no data on the interactions o
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
